Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 222

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015

Open access
Arnold, M., Holterhues, C., Hollestein, L.M., Coebergh, J.W.W., Nijsten, T., Pukkala, E., Holleczek, B., Tryggvadóttir, L., Comber, H., Bento, M.J., Diba, Ch.S., Micallef, R., Primic‐Žakelj, M., Izarzugaza, M.I., Perucha, J., Marcos‐Gragera, R., Galceran, J., Ardanaz, E., Schaffar, R., Pring, A., de Vries, E. · 2014 · Journal of the European Academy of Dermatology and Venereology

Abstract

Background: Melanoma is a significant health problem in Caucasian populations. The most recently available data from cancer registries often have a delay of several months up to a few years and they are generally not easily accessible. Objectives: To assess recent age‐ and sex‐specific trends in melanoma incidence and make predictions for 2010 and 2015. Methods: A retrospective registry‐based analysis was performed with data from 29 European cancer registries. Most of them had data available from 1990 up to 2006/7. World‐standardized incidence rates (WSR) and the estimated annual percentage change (EAPC) were computed. Predictions were based on linear projection models. Results: Overall the incidence of melanoma is rapidly rising and will continue to do so. The incidence among women in Europe was generally higher than in men. The highest incidence rates were seen for Northern and north‐western countries like the UK, I reland and the N etherlands. The lowest incidence rates were observed in P ortugal and S pain. The incidence overall remained stable in N orway, where, amongst young (25–49 years) Norwegian males rates significantly decreased (EAPC −2.8, 95% CI −3.6; −2.0). Despite a low melanoma incidence among persons above the age of 70, this age group experienced the greatest increase in risk during the study period. Conclusions: Incidence rates of melanoma are expected to continue rising. These trends are worrying in terms of disease burden, particularly in eastern European countries.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jdv.12236

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 222

Metadata

Authors
Arnold, M., Holterhues, C., Hollestein, L. M., Coebergh, J. W. W., Nijsten, T., Pukkala, E., Holleczek, B., Tryggvadóttir, L., Comber, H., Bento, M. J., Diba, C. S., Micallef, R., Primic‐Žakelj, M., Izarzugaza, M. I., Perucha, J., Marcos‐Gragera, R., Galceran, J., Ardanaz, E., Schaffar, R., Pring, A., & de Vries, E.
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2013-08-21
Volume
28
Issue
9
Pages
1170-1178
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2064173767
Cited by
222
References
2
FWCI
7.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. https://app.cochat.ai/papers/10.1111/jdv.12236
The paper
Arnold, M., Holterhues, C., Hollestein, L. M., Coebergh, J. W. W., Nijsten, T., Pukkala, E., Holleczek, B., Tryggvadóttir, L., Comber, H., Bento, M. J., Diba, C. S., Micallef, R., Primic‐Žakelj, M., Izarzugaza, M. I., Perucha, J., Marcos‐Gragera, R., Galceran, J., Ardanaz, E., Schaffar, R., . . . de Vries, E. (2014). Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.12236

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.